Disproportional response: a small company's current business is visibly outgrowing its own size
The model's full reasoning — Q3 2018 call → NOWe need to determine if management conveys that the business currently happening is visibly outgrowing the company's own size. The transcript discusses various topics: hurricane impact, tech updates, credit quality, competition, loan sales, expenses, etc. Management talks about being the largest SBA lender, but that's a leading position. They mention that they are not chasing competition, originations are down, they are focusing on expense control. They talk about holding more loans on balance sheet, but that's a strategic shift. They mention Apiture having 549 bank customers, but that's a separate venture. They talk about the company being small? They mention "we have $477 million of capital at the holding company and $377 million at the bank" - that's not small. They talk about being the largest SBA lender. They mention that they are not going to chase pricing. They talk about the secondary market being soft. They don't seem to convey that current business is disproportionately large relative to their size. They talk about reducing reliance on gain on sale, holding more loans, but that's not about outgrowing. They mention that they have the ability to portfolio up to $2 billion, but they are not going to do that. They talk about new verticals and general lenders, but that's future. They talk about the hurricane impact. They talk about the market being competitive. They don't say anything like "we are small and this opportunity is huge relative to us." They are a $3-5 billion bank, they are a leading SBA lender. So the answer is NO. But let's double-check: Is there any statement that conveys disproportion? For example, they mention that Apiture has 549 bank customers, but that's a separate company. They mention that SunTrust invested in Apiture, but that's not about Live Oak's own business. They talk about the tech update, but that's future. They talk about the hurricane, but that's operational. They talk about the secondary market, but that's a market condition. They talk about competition, but that's a challenge. They talk about expense management. They don't say "we are small and this is big." They are actually a large SBA lender. So answer NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| TMCI | Treace Medical Concepts, Inc. | Q2 2022 | 2022-08-13 | B+ |
| VNRX | VolitionRx Limited | Q1 2022 | 2022-05-12 | F |
| FLUX | Flux Power Holdings, Inc. | Q2 2022 | 2022-02-10 | D |
VNRX · Q1 2022 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES The transcript shows management explicitly describing the Heska deal (already signed and with $10M upfront received) as a long-term, multi-year commitment that will generate ongoing kit/component revenue "significantly greater" than the $28M milestones, with "millions of tests" expected each year — all while repeatedly noting the company is "not a big company" and that this is "the beginning of our commercial journey" after 12 years of R&D. They contrast this with their tiny current revenue ($114k) and cash position, framing the new activity as disproportionately large relative to their size.
TMCI · Q2 2022 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES Management explicitly describes the business as outgrowing its current setup in present-tense terms: they are “once again in the process of relocating to a larger headquarters facility” to meet “increased requirements” for training, R&D, warehousing, and infrastructure; the direct sales force has grown 52% to 123 quota-carrying reps and is already trending above the year-end 70% direct mix goal; surgeon penetration has reached 20% of the estimated 10,000 U.S. foot-and-ankle surgeons while procedure penetration is 4.6% of the 450,000 annual U.S.
KOPN · Q4 2023 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES The transcript shows management describing current activity (a $55 million backlog, a $20.5 million new order, follow-on orders, and tripled weapon-site volume expected in 2024) as large relative to the company’s still-small size and setup. They explicitly note the backlog is a “record level 10 years,” that they had to extend the holiday shutdown and retool the plant for a “significant increase in production,” and that they are “buying to that level of volume today” while remaining conservative on guidance.